Found 7 hits for monomerid = 50271150 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50271150
(CHEMBL4127116)Show SMILES CC(Nc1cc(F)cc(F)c1)c1cc(cc2ncc(nc12)N1CCOCC1)C(=O)NCCN(C)C Show InChI InChI=1S/C25H30F2N6O2/c1-16(30-20-13-18(26)12-19(27)14-20)21-10-17(25(34)28-4-5-32(2)3)11-22-24(21)31-23(15-29-22)33-6-8-35-9-7-33/h10-16,30H,4-9H2,1-3H3,(H,28,34) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Therachem Research Medilab (India) Pvt. Ltd.
Curated by ChEMBL
| Assay Description Inhibition of PI3Kbeta in human PC3 cells assessed as reduction in AKT phosphorylation at Thr308 residue measured after 60 mins by ELISA |
ACS Med Chem Lett 8: 778-780 (2017)
Article DOI: 10.1021/acsmedchemlett.7b00254 BindingDB Entry DOI: 10.7270/Q2TT4TFM |
More data for this Ligand-Target Pair | |
Serine/threonine-protein kinase mTOR
(Homo sapiens (Human)) | BDBM50271150
(CHEMBL4127116)Show SMILES CC(Nc1cc(F)cc(F)c1)c1cc(cc2ncc(nc12)N1CCOCC1)C(=O)NCCN(C)C Show InChI InChI=1S/C25H30F2N6O2/c1-16(30-20-13-18(26)12-19(27)14-20)21-10-17(25(34)28-4-5-32(2)3)11-22-24(21)31-23(15-29-22)33-6-8-35-9-7-33/h10-16,30H,4-9H2,1-3H3,(H,28,34) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | >3.02E+4 | n/a | n/a | n/a | n/a | n/a |
Therachem Research Medilab (India) Pvt. Ltd.
Curated by ChEMBL
| Assay Description Binding affinity to wild-type human MTOR (L1382 to W2549 residues) expressed in mammalian expression system by KINOMEScan assay |
ACS Med Chem Lett 8: 778-780 (2017)
Article DOI: 10.1021/acsmedchemlett.7b00254 BindingDB Entry DOI: 10.7270/Q2TT4TFM |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50271150
(CHEMBL4127116)Show SMILES CC(Nc1cc(F)cc(F)c1)c1cc(cc2ncc(nc12)N1CCOCC1)C(=O)NCCN(C)C Show InChI InChI=1S/C25H30F2N6O2/c1-16(30-20-13-18(26)12-19(27)14-20)21-10-17(25(34)28-4-5-32(2)3)11-22-24(21)31-23(15-29-22)33-6-8-35-9-7-33/h10-16,30H,4-9H2,1-3H3,(H,28,34) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | 2.51E+3 | n/a | n/a | n/a | n/a | n/a |
Therachem Research Medilab (India) Pvt. Ltd.
Curated by ChEMBL
| Assay Description Binding affinity to wild-type human PIK3Calpha (R108 to N1068 residues) expressed in mammalian expression system by KINOMEScan assay |
ACS Med Chem Lett 8: 778-780 (2017)
Article DOI: 10.1021/acsmedchemlett.7b00254 BindingDB Entry DOI: 10.7270/Q2TT4TFM |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50271150
(CHEMBL4127116)Show SMILES CC(Nc1cc(F)cc(F)c1)c1cc(cc2ncc(nc12)N1CCOCC1)C(=O)NCCN(C)C Show InChI InChI=1S/C25H30F2N6O2/c1-16(30-20-13-18(26)12-19(27)14-20)21-10-17(25(34)28-4-5-32(2)3)11-22-24(21)31-23(15-29-22)33-6-8-35-9-7-33/h10-16,30H,4-9H2,1-3H3,(H,28,34) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Therachem Research Medilab (India) Pvt. Ltd.
Curated by ChEMBL
| Assay Description Inhibition of PI3Kbeta in human PC3 cells assessed as reduction in AKT phosphorylation at S473 residue measured after 60 mins by ELISA |
ACS Med Chem Lett 8: 778-780 (2017)
Article DOI: 10.1021/acsmedchemlett.7b00254 BindingDB Entry DOI: 10.7270/Q2TT4TFM |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50271150
(CHEMBL4127116)Show SMILES CC(Nc1cc(F)cc(F)c1)c1cc(cc2ncc(nc12)N1CCOCC1)C(=O)NCCN(C)C Show InChI InChI=1S/C25H30F2N6O2/c1-16(30-20-13-18(26)12-19(27)14-20)21-10-17(25(34)28-4-5-32(2)3)11-22-24(21)31-23(15-29-22)33-6-8-35-9-7-33/h10-16,30H,4-9H2,1-3H3,(H,28,34) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | n/a |
Therachem Research Medilab (India) Pvt. Ltd.
Curated by ChEMBL
| Assay Description Binding affinity to wild-type human PIK3Cbeta (P118 to S1070 residues) expressed in mammalian expression system by KINOMEScan assay |
ACS Med Chem Lett 8: 778-780 (2017)
Article DOI: 10.1021/acsmedchemlett.7b00254 BindingDB Entry DOI: 10.7270/Q2TT4TFM |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50271150
(CHEMBL4127116)Show SMILES CC(Nc1cc(F)cc(F)c1)c1cc(cc2ncc(nc12)N1CCOCC1)C(=O)NCCN(C)C Show InChI InChI=1S/C25H30F2N6O2/c1-16(30-20-13-18(26)12-19(27)14-20)21-10-17(25(34)28-4-5-32(2)3)11-22-24(21)31-23(15-29-22)33-6-8-35-9-7-33/h10-16,30H,4-9H2,1-3H3,(H,28,34) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | 102 | n/a | n/a | n/a | n/a | n/a |
Therachem Research Medilab (India) Pvt. Ltd.
Curated by ChEMBL
| Assay Description Binding affinity to wild-type human PIK3Cdelta (R108 to Q1044 residues) expressed in mammalian expression system by KINOMEScan assay |
ACS Med Chem Lett 8: 778-780 (2017)
Article DOI: 10.1021/acsmedchemlett.7b00254 BindingDB Entry DOI: 10.7270/Q2TT4TFM |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM50271150
(CHEMBL4127116)Show SMILES CC(Nc1cc(F)cc(F)c1)c1cc(cc2ncc(nc12)N1CCOCC1)C(=O)NCCN(C)C Show InChI InChI=1S/C25H30F2N6O2/c1-16(30-20-13-18(26)12-19(27)14-20)21-10-17(25(34)28-4-5-32(2)3)11-22-24(21)31-23(15-29-22)33-6-8-35-9-7-33/h10-16,30H,4-9H2,1-3H3,(H,28,34) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | 1.74E+3 | n/a | n/a | n/a | n/a | n/a |
Therachem Research Medilab (India) Pvt. Ltd.
Curated by ChEMBL
| Assay Description Binding affinity to wild-type human PIK3Cgamma (S144 to A1102 residues) expressed in mammalian expression system by KINOMEScan assay |
ACS Med Chem Lett 8: 778-780 (2017)
Article DOI: 10.1021/acsmedchemlett.7b00254 BindingDB Entry DOI: 10.7270/Q2TT4TFM |
More data for this Ligand-Target Pair | |